On this page
Typically prepared by a compounding pharmacy under the direction of a licensed healthcare professional — not an FDA-approved finished product in this form.
Overview
Product & regulatory status
Compounded mixture rather than a single FDA-approved obesity medicine. Contents must be verified against the dispensing label.
Nutrient roles
Choline participates in cell membranes, acetylcholine production and lipid transport. Those normal roles do not prove that an injection enhances them usefully. [1]
What the evidence shows
Choline-deficiency evidence is not a fat-loss trial
A controlled feeding study in 57 adults found that severe choline deprivation could cause liver or muscle abnormalities, which improved when choline was restored. It did not test MIC injections or show extra fat loss in adequately nourished adults. [2]
B12 does not establish an energy benefit
NIH finds no established energy or endurance benefit from extra B12 in people with adequate status. Combining B12 with other nutrients does not itself demonstrate that the complete injectable mixture works. [3]
What remains unknown
Blend effectiveness, compatibility and long-term safety are not established by studies of individual oral nutrients. A proprietary name does not standardize a formula.
Safety
Sterile-product quality
A 2019 FDA-published recall included a MIC/B12 mixture because of potential lack of sterility. That specific recall illustrates a manufacturing risk, not proof that every current product is contaminated. [4]
More nutrient is not always harmless
Excess choline intake can cause adverse effects including low blood pressure and gastrointestinal symptoms; oral data do not define injectable-mixture safety. [1]
No universal blend
The recalled MIC/B12 product had a specific formula. Similarly named products need separate ingredient and quality verification. [4]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [5]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [6]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Does “lipotropic” prove it burns body fat?
No. The term describes a metabolic rationale, not demonstrated weight loss.
What should I request from the prescriber?
Request the exact formula and a controlled human study measuring the promised benefit.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- NIH: choline health-professional fact sheetNIH Office of Dietary Supplements; essential-nutrient roles, deficiency and excess-intake effects.
- Fischer et al.: human choline deprivation studyAmerican Journal of Clinical Nutrition, 2007; controlled feeding/depletion study in 57 adults, not a Lipo-C weight-loss trial.
- NIH: vitamin B12 health-professional fact sheetNIH Office of Dietary Supplements; B12 forms, deficiency, absorption, prescription forms and limits of energy claims.
- FDA: Pharm D Solutions sterile-product recall2019 company recall published by FDA; included a methionine/inositol/choline/methylcobalamin product, due to potential lack of sterility.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.